Bristol-Myers Squibb Company (NYSE: BMY ) looks ready to appreciate on the strength of a new drug approval, as well as improved technicals. The large cap pharmaceutical company performed poorly throughout 2023 and finally reached a capitulatory bottom in the springZvi provides advisory services to companies, trusts, and individuals, including consulting expert services regarding retirement and estate planning. Zvi is admitted to practice law in the state of New York, where he offers cash management, Bitcoin ...